Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
Authors
Keywords
Breast Cancer, Epithelial-mesenchymal transition, Metformin, STAT3, NF-κB, AMPK
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-23
DOI
10.1186/s12885-019-5945-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis
- (2018) Grace H. Tang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes
- (2018) Maria Eduarda Azambuja Amaral et al. INVESTIGATIONAL NEW DRUGS
- Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling
- (2018) Wanxing Duan et al. ONCOLOGY REPORTS
- Silencing Snail suppresses tumor cell proliferation and invasion by reversing epithelial-to-mesenchymal transition and arresting G2/M phase in non-small cell lung cancer
- (2017) Xueying Yang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
- (2017) Shoeb Ikhlas et al. LIFE SCIENCES
- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
- (2017) Qiuli Liu et al. Cell Death & Disease
- Metformin reverses bFGF-induced epithelial-mesenchymal transition in HCC cells
- (2017) Wang Chengye et al. Oncotarget
- Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition
- (2017) Imran Siddiqui et al. OncoImmunology
- Primary breast cancer cell culture yields intra-tumor heterogeneous subpopulations expressing exclusive patterns of receptor tyrosine kinases
- (2016) José Esparza-López et al. BMC CANCER
- Distinctive properties of metastasis-initiating cells
- (2016) Toni Celià-Terrassa et al. GENES & DEVELOPMENT
- The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
- (2016) Alexander M. Scherbakov et al. IUBMB LIFE
- Metformin induces apoptosis via a mitochondria-mediated pathway in human breast cancer cells in vitro
- (2016) ZHEN-YUAN GAO et al. Experimental and Therapeutic Medicine
- Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis
- (2016) Bodo E. Lippitz et al. OncoImmunology
- Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway
- (2015) Baiyu Han et al. TUMOR BIOLOGY
- IL-6 originated from breast cancer tissue-derived mesenchymal stromal cells may contribute to carcinogenesis
- (2015) Özlem Sağlam et al. TUMOR BIOLOGY
- Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
- (2015) Takla Griss et al. PLOS BIOLOGY
- Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial
- (2014) Konstantinos K. Tsilidis et al. DIABETES CARE
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9
- (2014) WEI SUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma
- (2014) JIN-WEI MIAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
- (2014) Zhongquan Zhao et al. PLoS One
- Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer
- (2013) Antoinette Hollestelle et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
- (2013) S. M. Hadad et al. Clinical & Translational Oncology
- Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells
- (2013) José Esparza-López et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
- (2013) Chao-Ying Liu et al. LABORATORY INVESTIGATION
- Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
- (2013) Russell A. Miller et al. NATURE
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Significance of the Correlation Between the Expression of Interleukin 6 and Clinical Features in Patients With Non-Small Cell Lung Cancer
- (2012) Eitetsu Koh et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
- (2012) Giovanni Blandino et al. Nature Communications
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
- (2011) Lev M. Berstein et al. MEDICAL ONCOLOGY
- Metformin and cancer: new applications for an old drug
- (2011) Taxiarchis V. Kourelis et al. MEDICAL ONCOLOGY
- Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
- (2011) Michael K. Wendt et al. MOLECULAR BIOLOGY OF THE CELL
- IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway
- (2011) A. Yadav et al. MOLECULAR CANCER RESEARCH
- Structure of mammalian AMPK and its regulation by ADP
- (2011) Bing Xiao et al. NATURE
- Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
- (2011) J.-P. Gillet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue
- (2010) Ian A Cree et al. CURRENT OPINION IN PHARMACOLOGY
- AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3)
- (2010) A. Nerstedt et al. DIABETOLOGIA
- Snail Family Regulation and Epithelial Mesenchymal Transitions in Breast Cancer Progression
- (2010) Antonio Garcia de Herreros et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Mechanisms of Motility in Metastasizing Cells
- (2010) Mahmut Yilmaz et al. MOLECULAR CANCER RESEARCH
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors
- (2009) Heehyoung Lee et al. CANCER CELL
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells
- (2009) N J Sullivan et al. ONCOGENE
- Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1
- (2009) I. Ota et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
- (2008) M Colomiere et al. BRITISH JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now